COVID-19 Vaccine: News
US Health Department's vaccine panel to review children's long-approved jabs
United States Health Secretary Robert F Kennedy Jr. has reconstituted the Advisory Committee on Immunization Practices (ACIP), a panel that advises the Centers for Disease Control and Prevention (CDC) on vaccination schedules.
FDA approves Moderna's next-gen COVID-19 vaccine for seniors
The US Food and Drug Administration (FDA) has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for people aged 65 and above.
Novak Djokovic opens up on 'trauma' from Australian Open deportation
Tennis maestro Novak Djokovic has opened up on the emotional turmoil he went through after being deported from Australia in 2022.
'I'm alive, happy, healthy': Shreyas Talpade shuts down death rumors
Actor Shreyas Talpade recently became the target of a viral death hoax that quickly spread across social media platforms.
India witnesses COVID-19 surge, health minister calls for mock drills
India on Wednesday witnessed a fresh surge in COVID-19 cases, with 614 new cases reported in the last 24 hours—reportedly the highest daily tally since May 21. This increase is attributed to the coronavirus sub-variant JN.1.
'The Vaccine War' trailer promises half-baked drama with mixed-up narratives
Vivek Agnihotri has become a famous name after the success of The Kashmir Files. His upcoming film The Vaccine War is in the buzz and now the makers have released the trailer of the same.
IIT Delhi develops new COVID-19 vaccine using immune cells
Researchers from IIT Delhi have developed a "nano-vaccine" for COVID-19, which has yielded promising results in animal studies.
India's 1st nasal COVID-19 vaccine by Bharat Biotech launched
Union Health Minister Dr. Mansukh Mandaviya and Science and Technology Minister Jitendra Singh on Thursday launched Bharat Biotech's iNCOVACC, which is reportedly India's first intranasal COVID-19 vaccine.
Bharat Biotech's iNCOVACC: Here's how much COVID-19 nasal vaccine costs
Hyderabad-based vaccine maker Bharat Biotech on Tuesday announced the price of its recently-approved intranasal COVID-19 vaccine, named iNCOVACC.
COVID-19: Mock drills across India to test preparedness; more updates
Amid a COVID-19 surge in neighboring China, a mock drill is being conducted at hospitals/healthcare centers across all Indian states and union territories on Tuesday to check the operational preparedness for dealing with a potential COVID-19 wave.
COVID-19 nasal vaccines are available but should you get one?
The Centre has given its nod to Bharat Biotech's nasal vaccine: iNCOVACC. It has been included in the COVID-19 vaccination program and has been approved to be used as a heterologous booster from today.
Novak Djokovic to be granted visa for Australian Open: Reports
Serbia's Novak Djokovic is set to receive his visa for the 2023 Australian Open.
COVID-19 vaccination boosts cancer treatment efficacy in patients: Study
Since the COVID-19 pandemic broke out in early 2020, its vaccines have become a point of discussion for several reasons.
Will Djokovic return at Australian Open? Director Craig Tiley answers
Serbian ace Novak Djokovic can compete at the 2023 Australian Open, provided he obtains a visa, according to tournament director Craig Tiley.
Bharat Biotech's nasal COVID-19 vaccine receives drug regulator's nod
The nasal vaccine for immunization against COVID-19, developed by Hyderabad-based vaccine maker Bharat Biotech, has received the approval of the Central Drugs Standard Control Organisation (CDSCO).
No concerning trends caused by new Omicron subvariants: Experts
Although India hasn't detected any concerning trends because of the discovery of new Omicron mutations—BA.4 and BA.5—experts have warned that people should remain vigilant against COVID-19.
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown
Confirming its first COVID-19 case on Thursday, North Korea ordered a nationwide lockdown calling it the "gravest national emergency."
COVID-19: India logs 2,927 new cases; 32 more deaths
India on Wednesday reported nearly 3,000 new COVID-19 cases, an increase of over 500 cases from the previous day.
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
In a significant move, the Drugs Controller General of India (DCGI) on Tuesday cleared two COVID-19 vaccines for use in children aged between five and 12 years.
Government considering COVID-19 booster dose for all adults: Report
The Modi government is considering making COVID-19 booster vaccine doses available to all adults, a Reuters report claimed, citing sources aware of the matter.
COVID-19 vaccination for 12-14 years begins; here's how to register
India on Wednesday started vaccination of children aged 12 to 14 years as it expands its COVID-19 vaccination coverage.
COVID-19 vaccination for 12-14-year-olds to start from Wednesday: Details here
In a major boost to India's COVID-19 vaccination efforts, India will start administering the vaccine against the novel coronavirus to children aged between 12 and 14 years from Wednesday.
COVID-19 oral vaccine's clinical trial to begin in India soon
Vaxart, a United States-based biotechnology company, is set to begin the second phase of clinical trial for its oral COVID-19 vaccine in India, according to a report by News18.
Centre rules out mixing up of vaccines for 'precautionary' dose
The Centre on Wednesday ruled out the mixing up of COVID-19 vaccines for the third "precautionary" dose.
5 lakh teens register to get COVID-19 vaccines from tomorrow
A day before India widens its COVID-19 vaccination drive to include teenagers aged 15-18 years, over five lakh such beneficiaries registered themselves to be inoculated.
Gurugram achieves 100% COVID-19 vaccination, 1st in Delhi-NCR
Gurugram has become the first district in Haryana to administer both doses of COVID-19 vaccines to all eligible civilians, the health department announced Tuesday.
SII to launch COVID-19 vaccine for children in 6 months
The Serum Institute of India is looking to launch a COVID-19 vaccine for children in six months, SII CEO Adar Poonawalla said Tuesday.
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
Seven COVID-19 vaccines are safe and stimulate a strong immune response when used as a booster jab to those who have already vaccinated, a study published in The Lancet said.
COVID-19: India reports 9K+ infections; 477 more deaths
India on Thursday reported over 9,000 new COVID-19 cases with an active caseload of just under one lakh.
Are Indian vaccines effective against Omicron? Here's what manufacturers say
The COVID-19 vaccine manufacturers in India are reportedly waiting for "more data" on the new coronavirus variant, Omicron, to assess the efficacy of their vaccines.
Policy on booster, additional jabs in 2 weeks: NTAGI chief
India's COVID-19 task force chief Dr. NK Arora said a comprehensive policy on the booster and additional COVID-19 vaccine jabs will be announced in two weeks.
COVID-19: India reports 8K+ infections; lowest in 538 days
India on Monday reported over 8,000 new COVID-19 cases, the lowest single-day tally in the last 538 days.
India exported 65 million COVID-19 vaccine doses this year: Modi
India exported over 65 million COVID-19 Vaccine doses to nearly 100 countries this year, said Prime Minister Narendra Modi on Thursday.
COVID-19: India reports 9K infections; lowest in 9 months
India on Tuesday reported nearly 9,000 new COVID-19 cases, which is the lowest daily tally in the last nine months.
COVID-19: India reports 10K+ infections; 125 more deaths
India on Monday reported over 10,000 new COVID-19 cases with an active caseload of 1.34 lakh, the lowest in 523 days.
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory
Hyderabad-based pharmaceutical company Biological E's COVID-19 vaccine Corbevex's samples were cleared by the Central Drugs Laboratory in Kasauli on Tuesday.
Kerala: Breakthrough infections account for most COVID-19 cases
Most COVID-19 cases reported in Kerala over the past two weeks involved breakthrough infections, official data showed.
COVID-19: India reports 12K new cases, 311 more deaths
India on Wednesday reported nearly 12,000 new COVID-19 cases with an active caseload of 1.51 lakh, the lowest in 252 days.
J&J vaccine's 1cr doses ready for export after CDL nod
American firm Johnson & Johnson's COVID-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are ready for export, News18 reported.
PM Modi to meet CMs, district officials over low vaccinations
The Union Health Ministry will convene a meeting on November 3 to boost the COVID-19 vaccination capacity of 11 states, whose numbers are lagging behind the national average.
COVID-19: India reports 15K+ new cases, 561 fresh fatalities
India on Sunday reported over 15,000 new COVID-19 cases with an active caseload of 1.72 lakh, the lowest in 235 days.
COVID-19: India reports 15K+ new cases, 231 more deaths
India on Friday reported over 15,000 new COVID-19 cases with an active caseload of 1.75 lakh, the lowest in 232 days.
Vaccination for children can wait as trial still underway: Expert
India's top virologist Dr. Gagandeep Kang has said that there should not be any hurry to vaccinate children against COVID-19 as vaccine trials are ongoing and immunogenicity data is still awaited.
COVAXIN recommended by expert panel for children aged 2-18 years
The Subject Expert Committee (SEC) on COVID-19 has recommended the approval of Bharat Biotech's COVAXIN for children aged between two and 18 years.
No quarantine for fully vaccinated Indians in UK from Monday
The United Kingdom has announced that Indians who are fully vaccinated with Covishield or any other UK-approved coronavirus vaccine will not have to quarantine upon arrival in Britain from Monday, October 11.
COVID-19 vaccination: 7% of India's population hesitant, finds survey
COVID-19 vaccine hesitancy among adult Indians has reduced to 7% of the total population, the lowest among Indians since January 2021, a survey has found.
WHO expert panel to discuss COVAXIN approval in meet today
COVAXIN, India's indigenous vaccine against the coronavirus, will likely receive the much-awaited approval from the World Health Organization (WHO) this month.
Coronavirus: 70% of India's adult population receive 1 vaccine dose
Union Health Minister Mansukh Mandaviya said on Monday that 70% of India's eligible adult population has been administered at least one COVID-19 vaccine dose.
ZyCoV-D expected to be rolled out in two weeks: Report
The indigenous COVID-19 vaccine developed by Zydus Cadila, called ZyCoV-D, is likely to be rolled out in the next two weeks.
COVID-19 vaccine booster: Are they really required? Expert answers
With the emergence of new coronavirus variants and talk of waning immunity of COVID-19 vaccines, discussions have been on about whether booster doses are required for the general public.
Vaccine diplomacy, Indo-Pacific security: Key takeaways from the Quad meeting
Prime Minister Narendra Modi attended the first in-person meeting of Quad (Quadrilateral Security Dialogue) leaders in Washington on Friday, hosted by United States President Joe Biden.
At-home COVID-19 vaccinations for those disabled, with restricted mobility
The central government on Thursday announced COVID-19 vaccinations at home for people who cannot reach vaccination centers due to restricted mobility or disabilities.
Vaccination certificates must meet minimum criteria: UK on travel rules
On the issue of the non-recognition of India's COVID-19 vaccine certification, the United Kingdom has maintained that the vaccine certificates of all countries must meet the minimum criteria.
COVID-19: How states are ensuring people get their second doses
As economic activities have mostly resumed across the country, state governments are putting all efforts to ensure people get their second dose of the COVID-19 vaccine.
UK recognizes Covishield, but Indians still need to quarantine
The United Kingdom on Wednesday revised its travel advisory, listing Covishield as an approved COVID-19 vaccine.